TransMedics (TMDX) Interest Expenses (2018 - 2026)

TransMedics has reported Interest Expenses for 9 years, with the latest figure at $7.2 million in Q1 2026.

• For the quarter ending Q1 2026, Interest Expenses rose 107.17% year-over-year to $7.2 million; the trailing twelve-month figure through Mar 2026 stood at $17.5 million (up 22.55% YoY), and the FY2025 full-year result was $13.8 million, down 4.35% from the prior year.
• Interest Expenses for Q1 2026 stood at $7.2 million, up from $3.4 million in the prior quarter.
• The five-year high for Interest Expenses was $7.2 million in Q1 2026, with the low at $787000.0 in Q3 2022.
• Average Interest Expenses over 5 years is $2.9 million, with a median of $3.5 million recorded in 2025.
• Year-over-year, Interest Expenses fell 19.61% in 2022 and jumped 356.16% in 2023.
• Tracing TMDX's Interest Expenses over 5 years: stood at $1.0 million in 2022, then surged by 257.99% to $3.6 million in 2023, then decreased by 0.94% to $3.6 million in 2024, then retreated by 6.08% to $3.4 million in 2025, then surged by 113.77% to $7.2 million in 2026.
• The last three Interest Expenses figures came in at $7.2 million (Q1 2026), $3.4 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.

Peer Comparison